Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

Clinical trial NCT06389513 · COMPLETED

Trial details

NCT number: NCT06389513
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Epidemic Meningitis

Start date: 2024-06-12
Primary completion: 2026-04-10
Enrollment: 3011

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.